240 related articles for article (PubMed ID: 15381022)
1. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA
Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
[TBL] [Abstract][Full Text] [Related]
2. Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease.
Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
J Neurophysiol; 2010 Feb; 103(2):942-9. PubMed ID: 20018839
[TBL] [Abstract][Full Text] [Related]
3. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
Tomer R; Aharon-Peretz J; Tsitrinbaum Z
Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
[TBL] [Abstract][Full Text] [Related]
4. Motor procedural learning in Parkinson's disease.
Muslimovic D; Post B; Speelman JD; Schmand B
Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
[TBL] [Abstract][Full Text] [Related]
6. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
Lange KW; Paul GM; Naumann M; Gsell W
J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
[TBL] [Abstract][Full Text] [Related]
9. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic medication boosts action-effect binding in Parkinson's disease.
Moore JW; Schneider SA; Schwingenschuh P; Moretto G; Bhatia KP; Haggard P
Neuropsychologia; 2010 Mar; 48(4):1125-32. PubMed ID: 20018200
[TBL] [Abstract][Full Text] [Related]
11. Sulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers.
Mehta MA; Hinton EC; Montgomery AJ; Bantick RA; Grasby PM
J Psychopharmacol; 2005 Jan; 19(1):29-38. PubMed ID: 15671126
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
13. Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.
Mehta MA; Swainson R; Ogilvie AD; Sahakian J; Robbins TW
Psychopharmacology (Berl); 2001 Dec; 159(1):10-20. PubMed ID: 11797064
[TBL] [Abstract][Full Text] [Related]
14. Striatal contribution to cognition: working memory and executive function in Parkinson's disease before and after unilateral posteroventral pallidotomy.
Jahanshahi M; Rowe J; Saleem T; Brown RG; Limousin-Dowsey P; Rothwell JC; Thomas DG; Quinn NP
J Cogn Neurosci; 2002 Feb; 14(2):298-310. PubMed ID: 11970793
[TBL] [Abstract][Full Text] [Related]
15. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
[TBL] [Abstract][Full Text] [Related]
16. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism.
Moustafa AA; Sherman SJ; Frank MJ
Neuropsychologia; 2008 Nov; 46(13):3144-56. PubMed ID: 18687347
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
[TBL] [Abstract][Full Text] [Related]
18. The impact of Parkinson's disease on sequence learning: perceptual pattern learning and executive function.
Price A; Shin JC
Brain Cogn; 2009 Mar; 69(2):252-61. PubMed ID: 18786754
[TBL] [Abstract][Full Text] [Related]
19. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
[TBL] [Abstract][Full Text] [Related]
20. Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.
Scholtissen B; Verhey FR; Adam JJ; Weber W; Leentjens AF
Clin Neuropharmacol; 2006; 29(5):276-85. PubMed ID: 16960473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
